Explorer les evidences

65,8 %More than half (65.8%) of the respondents were willing to vaccinate their adolescents against HPV.

Nigeriainfection à HPVpublié 2023West African journal of medicinePubMeddocument de 3 observations

6,8 aORAmong participants in the TRUST/RV368 cohort, 12 years or longer since anal coital debut was associated with highly similar anal HPV genotypes at 12 months (adjusted odds ratio 6.8, 95% CI 3.1–5.2).

Nigeriainfection à HPVpublié 2022Sexually transmitted diseasesPubMeddocument de 13 observations

92 %Among 342 men who have sex with men (MSM) in Nigeria, the prevalence of any HPV was 92%.

Nigeriainfection à HPVpublié 2020Papillomavirus research (Amsterdam, Netherlands)PubMeddocument de 19 observations

Mean HPV knowledge scores increased from 5.36 ± 6.26 to 23.41 ± 2.51 after the intervention.

Nigeriainfection à HPVPubMeddocument de 7 observations

19 %Among 213 women aged 16 to 63 years recruited in Lagos, Nigeria, 35 out of 187 concordant results were HPV positive, representing 19% of concordant cases.

Nigeriainfection à HPVobservé 2020publié 2022BMC public healthPubMeddocument de 5 observations

66,05 %Knowledge of HPV and cervical cancer among junior secondary school aged girls had a mean score of 66.05%.

Nigeriacancer du col de l'utérus · infection à HPVpublié 2022BMC public healthPubMeddocument de 6 observations

96,8 %Almost all of the parents (96.8%) had the intention to vaccinate their adolescents with HPV vaccine.

Nigeriainfection à HPVpublié 2022Human vaccines & immunotherapeuticsPubMeddocument de 3 observations

16,3 %In the study, 48 out of 295 individuals (16.3%) were successfully genotyped for HPV.

Nigeriainfection à HPVpublié 2019PloS onePubMeddocument de 7 observations

20 %Twenty percent of participants in the TRUST/RV368 cohort had highly similar anal HPV genotypes at 12 months.

Nigeriainfection à HPVpublié 2022Sexually transmitted diseasesPubMeddocument de 13 observations

42,4 %42.4% of the respondents have heard of HPV infection.

Nigeriainfection à HPVpublié 2023African journal of reproductive healthPubMeddocument de 5 observations

96,4 %Nearly all participants with oral HPV and EBV co-infection were females (96.4%).

Nigeriainfection à HPV · virus Epstein-Barrpublié 2025BMC oral healthPubMeddocument de 4 observations

53 %Fifty-three percent of participants in the TRUST/RV368 cohort had highly similar anal HPV genotypes at 3 months.

Nigeriainfection à HPVpublié 2022Sexually transmitted diseasesPubMeddocument de 13 observations

96 %Following the intervention, 96% of female secondary school students achieved high HPV knowledge.

Nigeriainfection à HPVPubMeddocument de 7 observations

13,2 %HPV was found in 13.2% of vaginal swabs among girls aged 9–20 years in central Nigeria.

Nigeriainfection à HPVpublié 2022BMC infectious diseasesPubMeddocument de 8 observations

63 %The prevalence of parental HPV vaccine acceptance was 63.0% among respondents in Abia State, Nigeria.

Nigeriainfection à HPVobservé 2023publié 2025The Pan African medical journalPubMeddocument de 10 observations

96,25 %Knowledge of HPV and cervical cancer among senior secondary school aged girls had a mean score of 96.25%.

Nigeriacancer du col de l'utérus · infection à HPVpublié 2022BMC public healthPubMeddocument de 6 observations

75 %The prevalence of any HPV infection was 75% in the anus among female sex workers in Ibadan, Nigeria.

Nigeriainfection à HPVpublié 2022PloS oneeurope_pmcdocument de 4 observations

50 %HPV-16 seroprevalence among women aged 15–19 years in Central Nigeria was 50.0%.

Nigeriainfection à HPVobservé August 2016 to January 2018publié 2021The Pan African medical journalPubMeddocument de 17 observations

3 %Awareness of HPV-associated oropharyngeal and female HPV-associated cancers ranged from 3% to 7% among the participants.

Nigeriafemale HPV-associated cancers · infection à HPV · oropharyngeal cancerpublié 2025Sexual healthPubMeddocument de 9 observations

42 %The overall pooled prevalence of cervical papillomavirus infection was 42% in the general population in Nigeria.

Nigeriainfection à HPVpublié 2020Asian Pacific journal of cancer prevention : APJCPPubMeddocument de 2 observations

89,8 %Compared to the medic-collected sample, the self-collected sample was 89.80% sensitive and 98.21% specific, with an accuracy of 96.31%, as determined using real-time PCR assay for HPV detection.

Nigeriainfection à HPVobservé 2020publié 2022BMC public healthPubMeddocument de 5 observations

40,98 %Among the PCR-confirmed HPV types, 40.98% were high-risk HPV types.

Nigeriainfection à HPVpublié 2023Virology journalPubMeddocument de 8 observations

1,3 %One point three percent of women had unresolved HPV infections.

Nigeriainfection à HPVpublié 2026Diagnostic microbiology and infectious diseasePubMeddocument de 21 observations

53,3 %About 53.3% of female undergraduates in a university in Ekiti State, southwest Nigeria, had fair knowledge of HPV.

Nigeriainfection à HPVpublié 2023African journal of reproductive healthPubMeddocument de 5 observations

18,2 %In the study, 18.2% of refusals for the HPV vaccine were due to fear of needles among students in four secondary schools in Benin City, Nigeria.

Nigeriainfection à HPVpublié 2026International journal of gynaecology and obstetrics: the official organ of the InternationPubMeddocument de 10 observations